Analyst Ratings & Stock Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at . These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by .

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
12/3/2018ReiteratesSeattle Genetics (SGEN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018ReiteratesCelgene (CELG)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018ReiteratesMEI Pharma (MEIP)Buy $7.50HighView Rating Details  Share on Twitter  Share on StockTwits
11/28/2018ReiteratesAcceleron Pharma (XLRN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/20/2018Reiterates1-800-Flowers.Com (FLWS)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018ReiteratesAgios Pharmaceuticals (AGIO)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018ReiteratesMEI Pharma (MEIP)Buy $7.50MediumView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018ReiteratesCytomX Therapeutics (CTMX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018ReiteratesMirati Therapeutics (MRTX)Buy$62.00 -> $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018ReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018InitiatesKura Oncology (KURA)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018ReiteratesTESARO (TSRO)Buy $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018ReiteratesCTI BioPharma (CTIC)Buy $4.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018ReiteratesSyros Pharmaceuticals (SYRS)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018ReiteratesAcceleron Pharma (XLRN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018ReiteratesMirati Therapeutics (MRTX)Buy $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018ReiteratesSeattle Genetics (SGEN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/21/2018ReiteratesMirati Therapeutics (MRTX)Buy $62.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018ReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/18/2018ReiteratesIntellia Therapeutics (NTLA)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
10/15/2018Reiterates1-800-Flowers.Com (FLWS)SellHighView Rating Details  Share on Twitter  Share on StockTwits
10/12/2018InitiatesCronos Group (CRON)Sell $4.50MediumView Rating Details  Share on Twitter  Share on StockTwits
10/12/2018InitiatesAphria (APHQF)Sell $19.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/12/2018InitiatesCanopy Growth (CGC)Sell $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018ReiteratesPyxus International (PYX)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018ReiteratesMEI Pharma (MEIP)Buy $7.50HighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018ReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018ReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018ReiteratesCTI BioPharma (CTIC)Buy $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018ReiteratesAmgen (AMGN)Buy $224.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018ReiteratesMiragen Therapeutics (MGEN)Buy $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/17/2018ReiteratesCrispr Therapeutics (CRSP)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
9/17/2018ReiteratesLoxo Oncology (LOXO)Buy $202.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/5/2018ReiteratesAgios Pharmaceuticals (AGIO)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
9/4/2018ReiteratesTESARO (TSRO)Buy $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/31/2018ReiteratesMEI Pharma (MEIP)Buy $7.50HighView Rating Details  Share on Twitter  Share on StockTwits
8/27/2018ReiteratesLoxo Oncology (LOXO)Buy $202.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/16/2018Lowers TargetConstellation Brands (STZ)Buy$234.00 -> $226.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/13/2018InitiatesConstellation Pharmaceuticals (CNST)Outperform $21.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018ReiteratesVerastem (VSTM)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018InitiatesClovis Oncology (CLVS)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018ReiteratesSyros Pharmaceuticals (SYRS)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018ReiteratesNeon Therapeutics (NTGN)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018ReiteratesMiragen Therapeutics (MGEN)Buy $19.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018ReiteratesEpizyme (EPZM)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018ReiteratesMirati Therapeutics (MRTX)Buy $62.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/30/2018ReiteratesAmgen (AMGN)Buy $224.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/23/2018InitiatesNeon Therapeutics (NTGN)Outperform $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/20/2018ReiteratesAgios Pharmaceuticals (AGIO)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
7/12/2018ReiteratesAcceleron Pharma (XLRN)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
7/12/2018ReiteratesLoxo Oncology (LOXO)Outperform -> Average$122.00 -> $202.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018Raises TargetMirati Therapeutics (MRTX)Outperform -> Average$35.00 -> $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018ReiteratesVerastem (VSTM)Outperform -> Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018ReiteratesMEI Pharma (MEIP)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018ReiteratesMiragen Therapeutics (MGEN)Outperform -> Buy$13.00 -> $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/28/2018ReiteratesAcceleron Pharma (XLRN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018Lowers TargetTESARO (TSRO)Outperform$122.00 -> $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018ReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
6/8/2018ReiteratesAmgen (AMGN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018ReiteratesTESARO (TSRO)Buy $122.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018ReiteratesExelixis (EXEL)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018ReiteratesExelixis (EXEL)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018ReiteratesSeattle Genetics (SGEN)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018ReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018ReiteratesAcceleron Pharma (XLRN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018ReiteratesIntellia Therapeutics (NTLA)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018ReiteratesKura Oncology (KURA)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018ReiteratesAgios Pharmaceuticals (AGIO)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/8/2018ReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018ReiteratesKura Oncology (KURA)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018InitiatesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018ReiteratesMEI Pharma (MEIP)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018ReiteratesExelixis (EXEL)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018ReiteratesSeattle Genetics (SGEN)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018Reiterates1-800-Flowers.Com (FLWS)SellMediumView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018ReiteratesExelixis (EXEL)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018ReiteratesCTI BioPharma (CTIC)Buy $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/2/2018ReiteratesInsys Therapeutics (INSY)AverageHighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018ReiteratesLoxo Oncology (LOXO)Buy $122.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018ReiteratesTESARO (TSRO)Buy$199.00 -> $122.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018ReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018UpgradesExelixis (EXEL)Market Perform -> Outperform $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018InitiatesCTI BioPharma (CTIC)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
2/21/2018InitiatesLoxo Oncology (LOXO)Outperform $132.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/16/2018ReiteratesEditas Medicine (EDIT)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
2/16/2018ReiteratesKura Oncology (KURA)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/15/2018ReiteratesCelgene (CELG)Buy $163.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018ReiteratesMEI Pharma (MEIP)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
2/2/2018ReiteratesMiragen Therapeutics (MGEN)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/26/2018ReiteratesVerastem (VSTM)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/12/2018InitiatesMiragen Therapeutics (MGEN)Outperform $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/8/2018ReiteratesAcceleron Pharma (XLRN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
1/8/2018ReiteratesMirati Therapeutics (MRTX)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/4/2018ReiteratesExelixis (EXEL)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
12/21/2017ReiteratesMEI Pharma (MEIP)Buy $6.50MediumView Rating Details  Share on Twitter  Share on StockTwits
12/12/2017ReiteratesEpizyme (EPZM)Buy $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/11/2017ReiteratesKura Oncology (KURA)Buy $17.50MediumView Rating Details  Share on Twitter  Share on StockTwits
12/11/2017ReiteratesMEI Pharma (MEIP)Buy $6.50HighView Rating Details  Share on Twitter  Share on StockTwits
12/10/2017ReiteratesVerastem (VSTM)Buy$6.00 -> $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/10/2017ReiteratesCrispr Therapeutics (CRSP)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
12/5/2017ReiteratesAgios Pharmaceuticals (AGIO)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
12/5/2017DowngradesTesla (TSLA)Hold -> SellLowView Rating Details  Share on Twitter  Share on StockTwits
11/30/2017ReiteratesAmgen (AMGN)Buy $205.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/22/2017ReiteratesCelgene (CELG)Buy $166.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2017ReiteratesCrispr Therapeutics (CRSP)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2017InitiatesSeattle Genetics (SGEN)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2017ReiteratesKura Oncology (KURA)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017ReiteratesTESARO (TSRO)Buy $199.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017ReiteratesEditas Medicine (EDIT)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017ReiteratesVerastem (VSTM)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2017ReiteratesEpizyme (EPZM)Buy $26.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/26/2017ReiteratesCelgene (CELG)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
10/16/2017ReiteratesExelixis (EXEL)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
10/6/2017ReiteratesAmgen (AMGN)Buy $203.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/19/2017ReiteratesEpizyme (EPZM)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/19/2017InitiatesMirati Therapeutics (MRTX)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
9/11/2017ReiteratesClovis Oncology (CLVS)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
9/8/2017ReiteratesTESARO (TSRO)Buy $199.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/8/2017ReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
9/5/2017ReiteratesAcceleron Pharma (XLRN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
8/29/2017ReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
8/28/2017ReiteratesAmgen (AMGN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
8/21/2017ReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/16/2017ReiteratesVerastem (VSTM)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
8/10/2017ReiteratesEditas Medicine (EDIT)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2017ReiteratesCytomX Therapeutics (CTMX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
8/1/2017ReiteratesCelgene (CELG)Buy $175.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/1/2017ReiteratesIntellia Therapeutics (NTLA)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
7/31/2017ReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
7/26/2017ReiteratesAmgen (AMGN)Buy$189.00 -> $203.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/25/2017ReiteratesVerastem (VSTM)Buy $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/20/2017ReiteratesExelixis (EXEL)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
7/17/2017InitiatesEditas Medicine (EDIT)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
7/17/2017InitiatesCrispr Therapeutics (CRSP)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
7/17/2017ReiteratesIntellia Therapeutics (NTLA)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
7/14/2017InitiatesHimax Technologies (HIMX)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
6/26/2017ReiteratesMEI Pharma (MEIP)Buy $6.50HighView Rating Details  Share on Twitter  Share on StockTwits
6/26/2017ReiteratesVerastem (VSTM)Buy $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/23/2017ReiteratesAcceleron Pharma (XLRN)Neutral -> HoldHighView Rating Details  Share on Twitter  Share on StockTwits
6/22/2017InitiatesClovis Oncology (CLVS)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
6/21/2017ReiteratesEpizyme (EPZM)Buy $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/19/2017ReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
6/13/2017ReiteratesAcceleron Pharma (XLRN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2017ReiteratesAgios Pharmaceuticals (AGIO)Buy $75.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/7/2017ReiteratesCelgene (CELG)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
6/5/2017ReiteratesMEI Pharma (MEIP)Buy $6.50MediumView Rating Details  Share on Twitter  Share on StockTwits
6/5/2017ReiteratesTESARO (TSRO)Buy $199.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/1/2017ReiteratesAcceleron Pharma (XLRN)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2017ReiteratesTESARO (TSRO)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
5/24/2017ReiteratesMEI Pharma (MEIP)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
5/15/2017ReiteratesKura Oncology (KURA)Buy $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/11/2017ReiteratesVerastem (VSTM)Buy $2.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2017UpgradesBoyd Gaming (BYD)Buy$20.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2017ReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/27/2017ReiteratesCelgene (CELG)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2017ReiteratesEpizyme (EPZM)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/19/2017ReiteratesExelixis (EXEL)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/19/2017ReiteratesAgios Pharmaceuticals (AGIO)Buy $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/12/2017ReiteratesVerastem (VSTM)Outperform $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/12/2017ReiteratesEpizyme (EPZM)Outperform $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/5/2017ReiteratesKura Oncology (KURA)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/4/2017ReiteratesCelgene (CELG)Buy $148.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/30/2017ReiteratesCytomX Therapeutics (CTMX)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017InitiatesSeattle Genetics (SGEN)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017InitiatesExelixis (EXEL)Market Perform -> PositiveHighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017ReiteratesKura Oncology (KURA)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017ReiteratesAmgen (AMGN)Outperform -> Positive $189.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/6/2017ReiteratesKura Oncology (KURA)Outperform $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/2/2017ReiteratesCelgene (CELG)Positive -> Outperform $148.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/1/2017ReiteratesAcceleron Pharma (XLRN)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
2/28/2017ReiteratesAmgen (AMGN)Positive -> Outperform $189.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/27/2017ReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/24/2017ReiteratesCelgene (CELG)Outperform $148.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/22/2017ReiteratesAmgen (AMGN)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
2/21/2017ReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/8/2017Raises TargetKura Oncology (KURA)Outperform $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/3/2017ReiteratesAmgen (AMGN)Buy $175.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/26/2017ReiteratesCelgene (CELG)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
1/24/2017ReiteratesSynaptics (SYNA)Underperform $45.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/17/2017UpgradesAgios Pharmaceuticals (AGIO)Market Perform -> Outperform $75.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/3/2017DowngradesHerman Miller (MLHR)Market Perform -> UnderperformN/AView Rating Details  Share on Twitter  Share on StockTwits
1/3/2017ReiteratesCytomX Therapeutics (CTMX)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
12/20/2016ReiteratesCelgene (CELG)Buy $141.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/16/2016ReiteratesAgios Pharmaceuticals (AGIO)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
12/12/2016InitiatesAcceleron Pharma (XLRN)Outperform$367.30 -> $44.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/12/2016InitiatesAmgen (AMGN)Buy $166.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/12/2016ReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/6/2016ReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/6/2016ReiteratesCelgene (CELG)Buy $141.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/6/2016ReiteratesCytomX Therapeutics (CTMX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/28/2016InitiatesAgios Pharmaceuticals (AGIO)Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
11/28/2016InitiatesSyros Pharmaceuticals (SYRS)Outperform $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/28/2016InitiatesCelgene (CELG)Outperform $141.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/8/2016DowngradesPier 1 Imports (PIR)Strong-Buy -> Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
3/11/2015UpgradesTullow Oil (TUWLF)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
2/27/2015UpgradesRIGHTMOVE PLC/ADR (RTMVY)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/27/2015UpgradesStandard Chartered (SCBFF)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
12/5/2014InitiatesJ D Wetherspoon (JDWPY)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
10/3/2014Lowers TargetCree (CREE) $41.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/15/2014InitiatesWhiting Petroleum (WLL)Buy $432.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/15/2014InitiatesContinental Resources (CLR)Buy $92.00N/AView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Wednesday at 09:06 PM ET.

MarketBeat Community Rating for

Community Ranking:  NaN out of 5 ()
Outperform Votes:  0 (Vote Outperform)
Underperform Votes:  0 (Vote Underperform)
Total Votes:  0
MarketBeat's community ratings are surveys of what our community members think about and other research firms. Vote "Outperform" if you believe 's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe 's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel